Project Grant R01GM166177
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $427,625 Project Grant to the University of Washington, effective September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of capillaric microfluidics technology for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry (MS) systems. The research addresses a...
- Federal Project Grant Award Summary Uforce Biotechnology, LLC received a $267,323 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on May 15, 2025, with completion targeted for April 30, 2026. The award funds development of a quantum sensing device that integrates super-resolution force spectroscopy (SURFS) with ultrasound technology to accelerate drug development and improve screening...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $423,330 to the University of Kansas Center for Research Inc. under the Biomedical Research and Research Training program (CFDA 93.859) for a five-year project period (August 1, 2025 – June 30, 2030). This Project Grant supports technology development initiatives focused on expanding biomedical research capabilities using mass spectrometry. The award builds on five years of prior MIRA (Maximizing...
- Federal Grant Award Summary Northeastern University received a $788,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, with completion targeted for June 30, 2030. The award supports development of quantum sensor-enhanced magnetic resonance techniques utilizing nitrogen-vacancy (NV) centers in diamond to achieve single-molecule detection capabilities. The...
- Federal Project Grant Award Summary Kansas State University received a $450,000 Project Grant from the National Science Foundation (NSF) Directorate for Engineering (CFDA 47.041) awarded July 1, 2026, with completion targeted for June 30, 2029. The project develops a gel electromicrofluidics (GEM) platform to enhance single-cell imaging and analysis capabilities for healthcare, medical diagnostics, and homeland security applications. The core deliverable is an integrated GEM-assisted platform...
- Federal Grant Award Summary Eastern Washington University received a $176,423 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026, with completion targeted for March 31, 2027. The primary deliverable is the acquisition and installation of an Akta Pure 25 Fast Protein Liquid Chromatography (FPLC) system for biomolecule purification at the institution. This instrument...
- Federal Project Grant Award Summary Arizona State University received a $1,977,264 Project Grant award, effective September 15, 2025, through August 31, 2029, under the National Institute of General Medical Sciences' Biomedical Research and Research Training program (CFDA 93.859). The award funds development of a novel multimodal imaging platform that integrates fluorescence super-resolution and tomographic polarized light imaging technologies to enable cellular and unicellular organism...
- Federal Project Grant Award Summary Texas Tech University System received a $119,870 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. The award supports the development of additive-manufactured organic granular magnetoresistive (OGMR) sensors integrated with machine learning algorithms for advanced cardiac health monitoring and arrhythmia...
- Federal Grant Award Summary The University of Massachusetts received a $396,854 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. The award supports the development of a nanopore tweezer toolkit designed to analyze kinase structural dynamics and screen allosteric inhibitors. This research leverages protein nanopore sensor technology to...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $436,361.00 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year project (August 1, 2025 – July 31, 2030) focused on advancing protein structure determination methodologies. The Research Foundation for the State University of New York, serving as the fiscal agent for research conducted in Buffalo, will develop innovative computational algorithms and...
Wichita State University's Office of Research and Sponsored Programs received a $534,074 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026 through June 30, 2029. The award funds the design, simulation, prototyping, and demonstration of a novel ultra-sensitive micro-resonator for X-band electron paramagnetic resonance (EPR) spectroscopy. The micro-resonator technology is intended to increase the sensitivity of current state-of-the-art X-band EPR spectrometers by an order of magnitude, enabling EPR analysis of diluted and volume-limited biomacromolecular samples—particularly metalloproteins, membrane proteins, and G-proteins that currently cannot yield measurable signals due to sample scarcity. The resonator will be designed for ease of manufacture using standard commercial printed circuit board substrates and seamless integration with existing X-band EPR equipment. This project addresses a significant gap in structural biology research, as proteins requiring purification in limited quantities constitute approximately 30 percent of all current drug targets. By enabling EPR characterization of previously intractable low-yield samples, the technology is expected to advance understanding of protein structure-function relationships critical to drug development and mechanistic studies of enzymes and reactive oxygen and nitrogen species quantification.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $534.1k | 7/3/26 |